Cargando…

Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature

Patients with neurofibromatosis type 1 (NF1) and Costello syndrome Rasopathy have behavioral deficits. In NF1 patients, these may correlate with white matter enlargement and aberrant myelin. To model these features, we induced Nf1 loss or HRas hyperactivation in mouse oligodendrocytes. Enlarged brai...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayes, Debra A., Rizvi, Tilat A., Titus-Mitchell, Haley, Oberst, Rachel, Ciraolo, Georgianne M., Vorhees, Charles V., Robinson, Andrew P., Miller, Stephen D., Cancelas, Jose A., Stemmer-Rachamimov, Anat O., Ratner, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982616/
https://www.ncbi.nlm.nih.gov/pubmed/24035394
http://dx.doi.org/10.1016/j.celrep.2013.08.011
_version_ 1782311203469524992
author Mayes, Debra A.
Rizvi, Tilat A.
Titus-Mitchell, Haley
Oberst, Rachel
Ciraolo, Georgianne M.
Vorhees, Charles V.
Robinson, Andrew P.
Miller, Stephen D.
Cancelas, Jose A.
Stemmer-Rachamimov, Anat O.
Ratner, Nancy
author_facet Mayes, Debra A.
Rizvi, Tilat A.
Titus-Mitchell, Haley
Oberst, Rachel
Ciraolo, Georgianne M.
Vorhees, Charles V.
Robinson, Andrew P.
Miller, Stephen D.
Cancelas, Jose A.
Stemmer-Rachamimov, Anat O.
Ratner, Nancy
author_sort Mayes, Debra A.
collection PubMed
description Patients with neurofibromatosis type 1 (NF1) and Costello syndrome Rasopathy have behavioral deficits. In NF1 patients, these may correlate with white matter enlargement and aberrant myelin. To model these features, we induced Nf1 loss or HRas hyperactivation in mouse oligodendrocytes. Enlarged brain white matter tracts correlated with myelin decompaction, downregulation of claudin-11, and mislocalization of connexin-32. Surprisingly, non-cell-autonomous defects in perivascular astrocytes and the blood-brain barrier (BBB) developed, implicating a soluble mediator. Nitric oxide (NO) can disrupt tight junctions and gap junctions, and NO and NO synthases (NOS1–NOS3) were upregulated in mutant white matter. Treating mice with the NOS inhibitor NG-nitro-L-arginine methyl ester or the antioxidant N-acetyl cysteine corrected cellular phenotypes. CNP-HRasG12V mice also displayed locomotor hyperactivity, which could be rescued by antioxidant treatment. We conclude that Nf1/Ras regulates oligodendrocyte NOS and that dysregulated NO signaling in oligodendrocytes can alter the surrounding vasculature. The data suggest that anti-oxidants may improve some behavioral deficits in Rasopathy patients.
format Online
Article
Text
id pubmed-3982616
institution National Center for Biotechnology Information
language English
publishDate 2013
record_format MEDLINE/PubMed
spelling pubmed-39826162014-04-10 Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature Mayes, Debra A. Rizvi, Tilat A. Titus-Mitchell, Haley Oberst, Rachel Ciraolo, Georgianne M. Vorhees, Charles V. Robinson, Andrew P. Miller, Stephen D. Cancelas, Jose A. Stemmer-Rachamimov, Anat O. Ratner, Nancy Cell Rep Article Patients with neurofibromatosis type 1 (NF1) and Costello syndrome Rasopathy have behavioral deficits. In NF1 patients, these may correlate with white matter enlargement and aberrant myelin. To model these features, we induced Nf1 loss or HRas hyperactivation in mouse oligodendrocytes. Enlarged brain white matter tracts correlated with myelin decompaction, downregulation of claudin-11, and mislocalization of connexin-32. Surprisingly, non-cell-autonomous defects in perivascular astrocytes and the blood-brain barrier (BBB) developed, implicating a soluble mediator. Nitric oxide (NO) can disrupt tight junctions and gap junctions, and NO and NO synthases (NOS1–NOS3) were upregulated in mutant white matter. Treating mice with the NOS inhibitor NG-nitro-L-arginine methyl ester or the antioxidant N-acetyl cysteine corrected cellular phenotypes. CNP-HRasG12V mice also displayed locomotor hyperactivity, which could be rescued by antioxidant treatment. We conclude that Nf1/Ras regulates oligodendrocyte NOS and that dysregulated NO signaling in oligodendrocytes can alter the surrounding vasculature. The data suggest that anti-oxidants may improve some behavioral deficits in Rasopathy patients. 2013-09-12 2013-09-26 /pmc/articles/PMC3982616/ /pubmed/24035394 http://dx.doi.org/10.1016/j.celrep.2013.08.011 Text en ©2013 The Authors http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Mayes, Debra A.
Rizvi, Tilat A.
Titus-Mitchell, Haley
Oberst, Rachel
Ciraolo, Georgianne M.
Vorhees, Charles V.
Robinson, Andrew P.
Miller, Stephen D.
Cancelas, Jose A.
Stemmer-Rachamimov, Anat O.
Ratner, Nancy
Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature
title Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature
title_full Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature
title_fullStr Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature
title_full_unstemmed Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature
title_short Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature
title_sort nf1 loss and ras hyperactivation in oligodendrocytes induce nos-driven defects in myelin and vasculature
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982616/
https://www.ncbi.nlm.nih.gov/pubmed/24035394
http://dx.doi.org/10.1016/j.celrep.2013.08.011
work_keys_str_mv AT mayesdebraa nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature
AT rizvitilata nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature
AT titusmitchellhaley nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature
AT oberstrachel nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature
AT ciraologeorgiannem nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature
AT vorheescharlesv nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature
AT robinsonandrewp nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature
AT millerstephend nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature
AT cancelasjosea nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature
AT stemmerrachamimovanato nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature
AT ratnernancy nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature